By John Halamka MD – Over the next 3 months, the HIT Standards Committee will review every detail of the 431 page Certification rule. We’ll also be holding calls to look at the rule as a whole. At least one call will be open to the general public. Think of this as reviewing the “trees” and the “forest”.
Read More
By Jim Tate – Lost in the furor and excitement of the recently released Proposed Stage 3 MU Rule something slipped by us. Robert Frost would say it “came on little cat feet”. John Lennon would say it came in “like a lizard on a window pane”. What is it that crept in through the cracks in the floor and why should we care?
By Jim Tate – “Things don’t change until they do.” I think Albert Einstein said that. Maybe it was Cat Stevens, I’m not really sure. We go along in our merry little lives content with the knowledge that the sun will come up tomorrow and summer will follow spring. All the rules that we rely on help us make sense of a chaotic universe.
By Matt Fisher – Advisory Opinion 15-04 issued by the Office of the Inspector General (“OIG”) on March 25, 2015 offers some warnings when entering into preferred provider agreements. The new Advisory Opinion arose in the context of laboratory services, but the principles discussed are easily applicable to any preferred provider arrangement. The advice and insight are important in light of the increasing desire among providers to identify and enter into preferred provider agreements.
CMS issued a new proposed rule for the Medicare and Medicaid EHR Incentive Programs to align Stage 1 and Stage 2 objectives and measures with the long-term proposals for Stage 3.
CMS issued a new proposed rule for the Medicare and Medicaid EHR Incentive Programs to align Stage 1 and Stage 2 objectives and measures with the long-term proposals for Stage 3.
CMS issued a new proposed rule for the Medicare and Medicaid EHR Incentive Programs to align Stage 1 and Stage 2 objectives and measures with the long-term proposals for Stage 3.
Cerner Corporation and Epic Systems have joined iPatientCare as CMS Designated Test EHR Program participants, which in the past have also included Meditech and McKesson.
By Seth Flam DO – The proposed rule for Meaningful Use Stage 3 is now available for comment. Look for it to be final later this year in the third quarter.